BUY Dr. Reddy's Laboratories — Sumeet Bagadia, 12 Sept 2026

bySumeet Bagadia, Choice BrokingHorizon: NA (inferred Swing (≤2wk))12 Sept 2026via LiveMint Buy-or-Sell (topic)

Entry₹1,165Stated

Target₹1,290

Stop loss₹1,100-5.58% risk

CMP₹1,165.51d ago

Active+0.04%+10.68%upside left 2 wk left

Follow Sumeet Bagadia for new calls(30% target hit, 290 closed calls)Get alerts Watch DRREDDY for new buy/sell callsGet alerts See 1 other Swing call on DRREDDY See 314 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 13 Sept, 7:11 am IST

3 supporting2 opposing

Supports the BUY call (3)

Dr Reddy's Mexico API facility gets 2 observations in US FDA records assessment

NewsCnbc-Tv18·11 Sept · yesterday

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·11 Sept · yesterday

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·11 Aug · 1mo ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (2)

MACD below its signal line — bearish momentum

Technicals · macd·13 Sept · today

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY

NewsGoogle News·10 Sept · 2d ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Dr. Reddy's Laboratories Limited — Sumeet Bagadia, Choice Broking

AI Assessment